Top Markets
Coin of the day
Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

FENC
Kedudukan dalam Saham #14216
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading... Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina.
Harga Saham
$12.33
Disegerakkan terakhir: 2026-08-31
Modal Pasaran
$428.31M
Perubahan (1 hari)
0.49%
Perubahan (1 tahun)
39.01%
Negara
US
Perdagangan Fennec Pharmaceuticals Inc. (FENC)

Kategori

Sejarah hasil dividen untuk Fennec Pharmaceuticals Inc. (FENC)
Hasil dividen (TTM) bagi Fennec Pharmaceuticals Inc. (simbol saham: FENC) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Fennec Pharmaceuticals Inc. (FENC) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
Syarikat Hasil Dividen Negara
0.00%
US
0.00%
NL
3.12%
AU
0.00%
US
0.00%
CH